Factors determining the total serum antioxidant capacity in men with coronary heart disease - The powerful effect of treatment with thienopyridines

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 6, 2014, Pages

  Gawron Skarbek, A ^a   Chrzczanowicz, J ^a,b   Kostka, J ^a   Nowak, D ^a   Drygas, W ^a   Jegier, A ^a   Kostka, T ^c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^c Cardiac Rehabilitation Centre Copernicus Memorial Hospital ^*  (Poland)

Author keywords

ACE inhibitors; Aspirin; Beta blockers; Free radicals; Statins; Uric acid

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIENOPYRIDINE DERIVATIVE; ANTIOXIDANT; BIOLOGICAL MARKER; CARDIOTONIC AGENT; TICLOPIDINE; URIC ACID;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CLINICAL ASSESSMENT; DRUG BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPECTROPHOTOMETRY; ANALOGS AND DERIVATIVES; BLOOD; COMPARATIVE STUDY; CORONARY DISEASE; DRUG COMBINATION; DRUG EFFECTS; MALE; MIDDLE AGED; OXIDATIVE STRESS;

ADULT; AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; CARDIOTONIC AGENTS; CORONARY DISEASE; DRUG THERAPY, COMBINATION; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; THIENOPYRIDINES; TICLOPIDINE; URIC ACID;

EID: 84901507324     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.02.011     Document Type: Letter

References (7)

1. Heitzer T., Rudolph V., Schwedhelm E., Karstens M., Sydow K., Ortak M., et al. Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects. Arterioscler Thromb Vasc Biol 2006, 26(7):1648-1652.
2. Lapenna D., de Gioia S., Ciofani G., Bruno C., Porreca E., Pierdomenico S.D., et al. Antioxidant properties of ticlopidine on human low density lipoprotein oxidation. FEBS Lett 1998;9, 436(3):357-360.
3. Fujimori S., Oka Y., Ogata N., Eto K. Effects of losartan/hydrochlorothiazide on serum uric acid levels and blood pressure in hypertensive patients. Nucleosides Nucleotides Nucleic Acids 2011, 30(12):1030-1034.
4. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;20, 342(3):145-153.
5. Benzie I.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996, 239(1):70-76.
6. Chrzczanowicz J., Gawron A., Zwolinska A., Graft-Johnson J., Krajewski W., Krol M., et al. Simple method for determining human serum 2,2-diphenyl-1-picryl-hydrazyl (DPPH) radical scavenging activity - possible application in clinical studies on dietary antioxidants. Clin Chem Lab Med 2008, 46(3):342-349.
7. Anfossi G., Russo I., Trovati M. Platelet dysfunction in central obesity. Nutr Metab Cardiovasc Dis 2009, 19(6):440-449.